CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 33 filers reported holding CATALYST BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,015 | +37.2% | 72,599 | 0.0% | 0.00% | – |
| Q2 2023 | $25,526 | +69.9% | 72,599 | 0.0% | 0.00% | – |
| Q1 2023 | $15,028 | -80.4% | 72,599 | -50.0% | 0.00% | – |
| Q4 2022 | $76,592 | +107.0% | 145,198 | +100.0% | 0.00% | – |
| Q3 2022 | $37,000 | -71.3% | 72,599 | 0.0% | 0.00% | – |
| Q2 2022 | $129,000 | +168.8% | 72,599 | 0.0% | 0.00% | – |
| Q1 2022 | $48,000 | -27.3% | 72,599 | 0.0% | 0.00% | – |
| Q4 2021 | $66,000 | -77.9% | 72,599 | 0.0% | 0.00% | – |
| Q3 2021 | $298,000 | +58.5% | 72,599 | +67.3% | 0.00% | – |
| Q2 2021 | $188,000 | -90.1% | 43,399 | -88.5% | 0.00% | – |
| Q1 2021 | $1,906,000 | -8.6% | 378,234 | +14.5% | 0.00% | – |
| Q4 2020 | $2,085,000 | +106.8% | 330,434 | +41.0% | 0.00% | – |
| Q3 2020 | $1,008,000 | -16.3% | 234,386 | +14.2% | 0.00% | – |
| Q2 2020 | $1,205,000 | -23.8% | 205,286 | +5.2% | 0.00% | – |
| Q1 2019 | $1,582,000 | -0.1% | 195,062 | -2.8% | 0.00% | – |
| Q4 2018 | $1,583,000 | -24.3% | 200,616 | +3.4% | 0.00% | – |
| Q3 2018 | $2,090,000 | -0.4% | 194,014 | +7.9% | 0.00% | – |
| Q2 2018 | $2,099,000 | +849.8% | 179,827 | +1999.3% | 0.00% | – |
| Q1 2018 | $221,000 | – | 8,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,635,014 | $10,830,000 | 4.93% |
| 22NW, LP | 1,429,242 | $5,874,000 | 1.75% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,110,000 | 1.20% |
| Sio Capital Management, LLC | 623,892 | $2,564,000 | 0.82% |
| ACUTA CAPITAL PARTNERS, LLC | 365,000 | $1,500,000 | 0.53% |
| Nantahala Capital Management | 2,432,212 | $9,996,000 | 0.32% |
| Parkman Healthcare Partners LLC | 133,449 | $548,000 | 0.14% |
| Ikarian Capital, LLC | 454,346 | $1,867,000 | 0.13% |
| Orbimed Advisors | 2,711,600 | $11,145,000 | 0.12% |
| AlphaCentric Advisors LLC | 114,000 | $469,000 | 0.12% |